MedPath

The Effect of Vitamin e on Depression and Anxiety in Postmenopausal Wome

Phase 3
Conditions
Depressive and Anxiety Disorder.
Mixed anxiety and depressive disorder
F41.2
Registration Number
IRCT20200307046719N1
Lead Sponsor
Ahvaz University of Medical Sciences
Brief Summary

Not available

Detailed Description

Not available

Recruitment & Eligibility

Status
Complete
Sex
Female
Target Recruitment
92
Inclusion Criteria

At least one year passed since the last menstruation.
Menopausal Married women.
Educated.
Ages between 45-65 years.
Earn a score 10-29 from Beck Depression Questionnaire for both groups.
Earn a score 8-25 from Beck Anxiety Questionnaire for both groups.

Exclusion Criteria

Consumption of vitamins and minerals, antidepressants and diuretics in the last 3 months.
Smoking history, using drugs and alcohol during the last 3 months.
History of mental or physical illness.
Occurrence of an unfortunate event during the last 6 months

Study & Design

Study Type
interventional
Study Design
Not specified
Primary Outcome Measures
NameTimeMethod
Anxiety. Timepoint: Before the intervention and eight weeks after the intervention. Method of measurement: Beck Anxiety Inventory.;Depression. Timepoint: Before the intervention and eight weeks after the intervention. Method of measurement: Beck Depression Inventory.
Secondary Outcome Measures
NameTimeMethod
© Copyright 2025. All Rights Reserved by MedPath